In a new draft guidance, issued on October 29, 2025, the FDA proposed major updates to simplify biosimilarity studies and potentially reduce ...

Many households in developing economies depend on coffee as a stable source of income. Coffee is also a staple product in many households around the world. However, coffee production via smallholdings ...

FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.

The Center for Biosimilars connects professionals with insights on biosimilars, health economics, regulatory outcomes, and ...

Islamic Capital Markets’ stands out for its comparative approach, pairing each conventional market or instrument with its ...

Goldman Sachs S&P 500 Premium Income ETF is rated 'Buy' for its dynamic strategy, 8%+ yield, and tech exposure. Read here for ...

Background Adverse childhood experiences (ACEs) are linked to poor health and social outcomes, with growing interest in their ...

In this age of globalization, where the world is tightly interconnected through production and markets, all countries compete ...

The convergence of AI-powered diagnostics, cloud-native platforms, and next-gen remote monitoring solutions is redefining how ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study in Cancers from The University of Texas MD Anderson Cancer Center showing how optical genome mapping (OGM) can address ...

The Food and Drug Administration (FDA) recently announced changes to its policy on when a comparative efficacy study would be required to ...